Equities researchers at StockNews.com began coverage on shares of Aptiv (NYSE:APTV – Get Free Report) in a research report issued on Sunday. The brokerage set a “hold” rating on the auto parts company’s stock.
Other equities analysts also recently issued reports about the stock. Wells Fargo & Company raised shares of Aptiv from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $78.00 to $87.00 in a research note on Friday, September 20th. Barclays dropped their target price on shares of Aptiv from $105.00 to $100.00 and set an “overweight” rating for the company in a research note on Monday, August 5th. JPMorgan Chase & Co. boosted their target price on shares of Aptiv from $107.00 to $113.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Fox Advisors downgraded shares of Aptiv from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, October 1st. Finally, Evercore ISI dropped their target price on shares of Aptiv from $125.00 to $115.00 and set an “outperform” rating for the company in a research note on Monday, July 15th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $87.00.
Get Our Latest Stock Report on Aptiv
Aptiv Trading Down 0.8 %
Aptiv (NYSE:APTV – Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The auto parts company reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.68 by $0.15. Aptiv had a net margin of 12.29% and a return on equity of 14.51%. The firm had revenue of $4.85 billion during the quarter, compared to the consensus estimate of $5.10 billion. During the same period last year, the firm posted $1.30 EPS. The firm’s quarterly revenue was down 5.1% on a year-over-year basis. Research analysts forecast that Aptiv will post 6.23 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of APTV. Independence Bank of Kentucky acquired a new position in Aptiv during the second quarter valued at approximately $25,000. Crewe Advisors LLC grew its holdings in Aptiv by 94.7% during the second quarter. Crewe Advisors LLC now owns 442 shares of the auto parts company’s stock valued at $31,000 after purchasing an additional 215 shares during the period. Clearstead Trust LLC boosted its holdings in shares of Aptiv by 305.0% in the first quarter. Clearstead Trust LLC now owns 405 shares of the auto parts company’s stock valued at $32,000 after buying an additional 305 shares during the period. Wolff Wiese Magana LLC boosted its holdings in shares of Aptiv by 44.3% in the third quarter. Wolff Wiese Magana LLC now owns 505 shares of the auto parts company’s stock valued at $36,000 after buying an additional 155 shares during the period. Finally, Cullen Frost Bankers Inc. acquired a new position in shares of Aptiv in the second quarter valued at approximately $38,000. Institutional investors and hedge funds own 94.21% of the company’s stock.
Aptiv Company Profile
Aptiv PLC engages in design, manufacture, and sale of vehicle components in North America, Europe, Middle East, Africa, the Asia Pacific, South America, and internationally. The company provides electrical, electronic, and safety technology solutions to the automotive and commercial vehicle markets. It operates through two segments, Signal and Power Solutions, and Advanced Safety and User Experience.
Featured Articles
- Five stocks we like better than Aptiv
- The How and Why of Investing in Gold Stocks
- Intel: Is Now the Time to Be Brave?Â
- How Investors Can Find the Best Cheap Dividend Stocks
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Bank Stocks – Best Bank Stocks to Invest In
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Aptiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptiv and related companies with MarketBeat.com's FREE daily email newsletter.